A regulatory non-interventional study to monitor the safety and efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean patients with Chronic Kidney Disease (CKD)First published 24/10/2023 Last updated 24/07/2024 EU PAS number: EUPAS107293StudyOngoing